ArticleO&G open2024
Telehealth in Gynecologic Oncology Clinical Trials: Qualitative Study of Patient, Researcher, and Clinician Perspectives.
Article in O&G open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Ethical Challenges and Considerations in Decentralized Clinical Trials (DCTs): Insights from a Scoping Review.Therapeutic innovation & regulatory science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
objectiveTo describe patient, research staff, and clinician perspectives regarding the effects of telehealth and remote clinical trial operations on safety, quality, and experience in gynecologic oncology clinical trials.
methodsThis qualitative study used semistructured interviews conducted from May to June 2022 with purposively sampled clinical trial participants, research staff, and clinicians involved in gynecologic oncology clinical trials with telehealth utilization. Participants described telehealth in clinical trial experiences, including benefits and barriers to receipt and provision of care, satisfaction, and quality. Transcripts were coded and analyzed with a modified content analysis approach based on research objectives and emergent themes. An adapted version of the validated Telehealth Usability Questionnaire was administered to all invited participants.
resultsFive patients, seven clinicians, and five research staff were interviewed. Patients and clinicians reported that telehealth, remote testing, and medication delivery positively affected quality of life by reducing financial burden, wait times, and transportation needs. Interviewees did not report telehealth-related changes in treatment-related adverse effects, referrals for urgent evaluation, or compromise of privacy but expressed concerns about the lack of physical examinations. Patients reported that telehealth increased scheduling burden without negative effects on care quality, counseling comprehension, relationships with trial teams, or satisfaction. Clinicians and research staff reported improved workflows regarding remote consent, sponsor interactions, and documentation but challenges with virtual patient education and off-site testing. Clinicians highlighted disparities for patients with limited technology access and reported institutional and insurance-based telehealth policies as barriers. Survey responses supported qualitative findings.
conclusionDespite notable limitations, patients, research staff, and clinicians recommended continued utilization of telehealth and remote clinical trial operations in clinical trials. Future clinical trial designs should consider telehealth inclusion.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.